This is an archived article that was published on sltrib.com in 2016, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.
Troubled blood-testing startup Theranos says it will continue serving customers through independent retail locations a day after the nation's largest drugstore chain severed ties with the company.
Walgreens had said Sunday that it will immediately close all 40 Theranos Wellness Centers at the drugstore chain's Arizona locations.
In January, Walgreens Boots Alliance Inc. told Theranos to stop sending samples collected at its stores to a testing facility that drew regulatory scrutiny over possible patient risks.
Theranos said Monday in a brief statement posted on its website that it was disappointed with the Walgreens decision.
The blood-testing company said it was working with government officials "to ensure that we not only comply with all federal regulations but exceed them," and it still would serve customers in California and Arizona through the independent retail locations.
Palo Alto, Calif.-based Theranos has raised millions of dollars by pitching its technology as a cheaper, faster way to run blood tests.
The privately held company said in April that it was under investigation from several regulators and agencies. That followed a series of Wall Street Journal reports that raised questions about the company's tests.